Oxford and AstraZeneca are resuming coronavirus vaccine trials after a participant fell ill

Business Insider

12 Sep 2020 0 shares 1 views

Oxford and AstraZeneca are resuming coronavirus vaccine trials after a participant fell ill

Oxford and AstraZeneca are resuming coronavirus vaccine trials after a participant fell ill

Business Insider

Published 12 Sep 2020

Trials have resumed in the UK after an independent review board concluded it was safe to do so after a participant fell ill earlier this week.

You might like

Related news coverage

Covid 19 coronavirus: Mystery illness that stopped vaccine trial

Covid 19 coronavirus: Mystery illness that stopped vaccine trial

New Zealand Herald 16 Sep 2020

A trial participant for a promising Covid-19 vaccine suffered from mysterious neurological symptoms including limb weakness or..

Mumbai: Clinical trial of COVID-19 vaccine begins at KEM, Nair hospitals
Mid-Day 27 Sep 2020
Mumbai: KEM hospital gets gets nod for COVID-19 vaccine trials
Mid-Day 23 Sep 2020
Second AstraZeneca trial participant develops rare neurological condition following COVID-19 vaccination
NaturalNews.com 22 Sep 2020
COVID-19 vaccination to be available by 'start of next year': Harsh Vardhan
Mid-Day 17 Sep 2020

Advertisement

More coverage

Covid 19 vaccine race – who’s in pole position?

Covid 19 vaccine race – who’s in pole position?

Invezz 15 Sep 2020

A number of companies and research teams around the globe are struggling to develop a vaccine against the SARS-CoV-2 virus, which..

AstraZeneca vaccine trial illness unlikely to be linked to shot, Oxford says
Brisbane Times 16 Sep 2020
Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine
Mid-Day 16 Sep 2020
'AstraZeneca hasn't resumed trial in US'
Mid-Day 16 Sep 2020
COVID-19 outbreaks at colleges worry experts as some students continue to ignore health rules
CBS News 14 Sep 2020